Search Results (317)

Endometritis—inflammation of the endometrial lining—imposes a substantial reproductive and economic burden in both human gynecology and livestock production, where it is a leading cause of recurrent implantation failure in humans and the costliest reproductive disorder in cattle. Conventional management is overwhelmingly antibiotic-based, yet escalating antimicrobial resistance, tissue and milk residues, microbiota disruption and high relapse rates have eroded its efficacy and acceptability, creating an urgent need for mechanism-based, host-directed alternatives. Here we synthesize the expanding evidence positioning dietary flavonoids and traditional Chinese medicine (TCM) formulations as such interventions. Across diverse compounds and preparations, anti-endometriotic activity converges on a tractable set of molecular nodes: TLR4/NF-κB signaling, the NLRP3 inflammasome–pyroptosis axis, the Keap1/Nrf2/HO-1 antioxidant program, PI3K/AKT and PPAR-γ signaling, ferroptosis, and the gut–uterus microbial–metabolite axis. Veterinary field studies report cure rates and fertility outcomes rivaling first-line antibiotics, while integrative case reports show benefit in antibiotic-refractory human chronic endometritis. Translation remains constrained by poor bioavailability, formulation heterogeneity, over-reliance on lipopolysaccharide-only models and a scarcity of randomized trials—barriers now addressable through nanocarrier delivery, network-pharmacology-guided standardization and biomarker-stratified designs. Flavonoids and TCM are best viewed not as substitutes for antibiotics but as a mechanistically rational, multi-target strategy aligned with One Health antimicrobial stewardship. Full article

This review analyses and logically structures modern intelligent sensor technologies in the context of animal husbandry, feed production, and veterinary medicine. The main research discussed in the article focuses on machine learning based on modern neural network models, computer vision, and sensor systems that are transforming the methods for assessing the health, behavior, and nutrition of farm animals. The first part examines modern approaches to quality control and optimization of mineral and vitamin premixes, including visual inspection using visual sensors and neural networks. Key roles are played by precise dosing, component stability (minerals, vitamins), and the transition to more bioefficient organic forms of micronutrients to reduce environmental impact. Improvements in feed and premix production are analyzed, including automation, energy management, and the use of machine learning for non-destructive quality control, defect detection, mixing homogeneity assessment, and vitamin stability prediction. The second part analyzes methods for animal location and behavior detection. This article presents computer vision-based systems, including modifications of YOLO, for automatically tracking and classifying key behavioral patterns (lying down, standing, feeding, and aggression) in cattle and pigs, even in crowded conditions. It also discusses the use of ultra-wideband (UWB) systems and accelerometers combined with machine learning for high-precision positioning and detection of specific behavioral anomalies, such as lameness and playfulness. The third section focuses on the application of machine learning in veterinary diagnostics, including the automated interpretation of medical images (X-ray, ultrasound, and MRI) as sensor data streams for the diagnosis of cardiovascular, oncological, and orthopedic diseases in farm and small animals. Furthermore, the article examines the use of machine learning models for proactive disease diagnosis in farm animals and poultry based on multimodal data and image analysis. Considerable attention is given to methods and tools for radiometric diagnosis of animal diseases at an early stage using microwave sensors, as well as laser therapy and surgery in veterinary medicine. The review concludes that the integration of intelligent systems enables a transition to data-driven livestock management, significantly improving animal welfare and, consequently, the efficiency and sustainability of agricultural production. Full article

In the female organism, Anti-Müllerian hormone (AMH) is produced exclusively by granulosa cells, particularly in secondary and early tertiary follicles. The amount of AMH released into the blood is proportional to the total number of follicles present in the ovaries and is therefore used to estimate the ovarian functional reserve. In both cattle and mares, a strong and highly repeatable association has also been demonstrated between AMH concentrations and antral follicle count. Therefore, AMH may serve as a biomarker with broad diagnostic utility in reproductive medicine in these species, as it reflects the functional ovarian reserve through its association with viable antral and preantral follicles. While AMH is already being used for clinical diagnostics in human reproductive medicine and has been extensively investigated, it has received little attention in applied veterinary practice so far. This review explores the applications of AMH for reproductive medicine in cattle and horses, monoovulatory farm animals in which assisted reproductive technologies are widely used. The objectives of this review are to (I) provide clinically relevant background information and a comparative discussion of (II) the role of AMH in follicular development, (III) its value as a fertility indicator, and (IV) its significance for embryo production in vivo and in vitro in cows and mares, with particular emphasis on practical relevance and potential applications. Full article

Effective reprocessing of surgical instruments is essential to prevent healthcare-associated infections in the field of veterinary medicine. However, chemical disinfectants are frequently used as alternatives to sterilization in small animal clinics, particularly in resource-limited settings. This preliminary exploratory study evaluated routine chemical disinfection practices and residual bacterial contamination of surgical instruments in veterinary clinics in Veracruz, Mexico. A cross-sectional study was conducted in ten small animal veterinary clinics. Samples were collected from the surgical instruments and operative surfaces immediately after routine chemical disinfection. Bacterial isolation was performed using conventional culture methods, and microbial identification was performed using MALDI-TOF mass spectrometry. Descriptive analysis and Fisher’s exact test were used to explore the association between disinfectant category and bacterial contamination. Bacterial growth was detected in 19 of the 60 samples (31.6%). The identified microorganisms included Bacillus, Staphylococcus, Pseudomonas, Acinetobacter, and Burkholderia species. Most clinics relied on low-level disinfectants, particularly benzalkonium chloride (BAC). Residual contamination was more commonly observed in clinics reporting the use of low-level disinfectants, particularly benzalkonium chloride-based products. However, these findings should be interpreted cautiously because of the exploratory observational design and limited sample size. These results suggest that routine chemical disinfection, particularly when low-level disinfectants are used, may not always achieve complete microbial elimination under real-world clinical conditions. Improved infection prevention and instrument reprocessing practices are required in veterinary clinical settings. From a One Health perspective, strengthening infection control measures in veterinary clinics may help reduce microbial circulation among animals, veterinary personnel, and the environment. Full article

Colitis is a chronic relapsing inflammatory disorder characterized by persistent mucosal inflammation, epithelial barrier disruption, oxidative stress, immune dysregulation, and gut microbiota imbalance. Although current therapies have improved disease management, their long-term use is still limited by incomplete response, relapse, adverse effects, and high cost. Natural products have attracted increasing attention as promising candidates for colitis intervention because of their structural diversity, broad bioactivity, and multitarget regulatory potential. In veterinary medicine, colitis and colitis-related intestinal inflammatory disorders are also clinically relevant in companion animals, horses, and food-producing animals, where they contribute to diarrhea, impaired intestinal barrier function, reduced performance, treatment costs, and antimicrobial-use concerns. Therefore, natural products may have additional value as adjunctive, nutritional, or microbiota-modulating strategies in veterinary and comparative gastroenterology. This review summarizes the major categories of natural products investigated for colitis, including flavonoids, polyphenols, alkaloids, terpenoids, saponins, polysaccharides, plant extracts, and traditional herbal formulas, and discusses their principal mechanisms of action, such as anti-inflammatory activity, attenuation of oxidative stress, restoration of intestinal barrier integrity, modulation of immune responses, regulation of gut microbiota, and control of programmed cell death. We also highlight the major limitations of current research, including overreliance on preclinical models, insufficient target validation, poor bioavailability, and limited clinical evidence. Overall, natural products represent an important source of therapeutic candidates for colitis, but their clinical translation will require deeper mechanistic studies, standardized evaluation, and well-designed clinical investigations. Importantly, future studies should distinguish phenotype-associated changes from causal mechanisms by integrating direct target engagement, functional rescue experiments, microbiota-causality validation, and standardized pharmacokinetic and safety assessment. Full article

Interest in phytotherapy and phytogenic additives in veterinary medicine and animal production has increased considerably, driven by the search for functional alternatives to extensive antimicrobial use and the growing emphasis on food safety. In this context, Curcuma longa L. and its main bioactive compound, curcumin, have attracted attention because of their antioxidant, anti-inflammatory, immunomodulatory and antimicrobial properties. This review synthesizes recent evidence on the use of C. longa and curcumin in veterinary medicine, with emphasis on the botanical and phytochemical basis of the plant, the main biological mechanisms involved, and reported applications in poultry, swine, ruminants, aquaculture, and companion animals. It further highlights that the interpretation of findings is strongly influenced by botanical identity, phytochemical variability, product type, standardization, dose and route of administration. Available evidence indicates promising effects on antioxidant status, intestinal health, productive performance and hepatic protection in selected experimental models. However, translation into practice remains constrained by the low oral bioavailability of curcumin, formulation heterogeneity and inconsistent reporting. Overall, C. longa represents a promising phytogenic resource, but robust veterinary recommendations require studies in target species, better characterized products and standardized experimental protocols for application. Full article

The increasing demand for sustainable and antibiotic-free veterinary practices has stimulated interest in natural products such as clinoptilolite, ozone therapy, bee-derived products, and phytotherapy. This systematic review evaluates evidence from 2010 to 2026 regarding their clinical efficacy and mechanisms of action. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, CAB Abstracts, Google Scholar, and regional veterinary journals using predefined keywords related to natural alternatives in veterinary medicine. These studies were critically appraised due to frequent methodological limitations, including lack of randomization and control groups. From 1124 identified records, 842 studies were screened after duplicates were removed, 214 full-text articles were assessed for eligibility. A total of 96 studies meeting the predefined inclusion criteria were included in the final analysis. Clinoptilolite consistently improved gastrointestinal health and detoxification in livestock. Ozone therapy demonstrated broad antimicrobial and immunomodulatory effects, though standardized protocols are lacking. Bee-derived products, especially propolis exhibited strong antimicrobial and antioxidant properties, with variable clinical translation. Phytotherapy emerged as a promising alternative to antibiotic growth promoters. Overall, the available evidence suggests that these natural interventions may serve as promising adjuncts in veterinary practice; however, their current application is constrained by heterogeneity, limited randomized controlled trials, and lack of standardized protocols. Consequently, they should be considered supportive rather than definitive alternatives to conventional therapies. Further well-designed, standardized clinical studies are required to confirm efficacy, optimize application, and support evidence-based integration into modern veterinary medicine. Full article

Feline infectious peritonitis virus (FIPV) remains one of the most challenging viral diseases in veterinary medicine, largely owing to the absence of a consistently effective and safe vaccine. Despite widespread feline coronavirus infection, only a subset of infected cats progresses to feline infectious peritonitis, indicating that host immune responses are key determinants of disease outcomes. Accumulating evidence indicates that disease severity is driven not only by viral replication but also by macrophage- and monocyte-centered immune signaling, leading to excessive inflammation and systemic immunopathology in the host. Previous vaccine approaches against FIPV have failed to provide consistent protection and, in some cases, have been associated with enhanced disease. These outcomes suggest that vaccine-induced immune responses that recapitulate pathogenic signaling patterns may exacerbate disease rather than confer protection. In this review, we discuss the current knowledge of immune cell signaling pathways implicated in FIPV infection, including innate sensing through Toll-like receptors, downstream mitogen-activated protein kinases and NF-κB signaling, cytokine production profiles, Fc receptor-associated processes, and intracellular pathways such as autophagy, and how these mechanisms shape vaccine-induced immunity. By integrating insights from immune signaling kinetics, antibody functionality, adjuvant-driven pathway engagement, and platform-specific immune signatures, this review emphasizes the need to reframe FIPV vaccine development strategies that actively shape host immune responses. Rather than maximizing immunogenicity, successful vaccine design is likely to depend on limiting sustained macrophage activation and pro-inflammatory cytokine amplification while supporting antiviral immune functions, thereby reducing the risk of antibody-dependent enhancement and immunopathology. Beyond feline diseases, these considerations provide broader lessons for vaccine design in settings where immune-mediated pathology contributes to disease severity. Full article

The skin represents the largest organ in the body and functions to protect internal tissues from damage and infection. When wounds in small animals do not receive proper management, they may progress to chronic conditions, resulting in pain, delayed healing, and impaired well-being. Although conventional treatment mainly includes the use of topical antimicrobial agents and anti-inflammatory drugs, integrative veterinary medicine has been considered a promising complementary approach to enhance tissue repair. In this context, this study aimed to review non-conventional therapies applied to wound management in small animals, focusing on ozone therapy, light therapy that stimulates cellular activity, herbal medicine, and apitherapy, especially propolis. Overall, the analyzed studies indicate that ozone may contribute to microbial control and modulation of the immune response; light therapy may stimulate cellular activity and collagen production, promoting healing; medicinal plants present antioxidant and anti-inflammatory effects; and propolis demonstrates antimicrobial and regenerative properties. Thus, when responsibly applied and supported by scientific evidence, these approaches may complement conventional therapy, broaden clinical possibilities, and contribute to improved recovery and quality of life in animals. Full article

Skin wound management in veterinary medicine requires therapies able to control inflammation, limit microbial burden, and support tissue repair. This study evaluated the anti-inflammatory, wound-healing, and immunomodulatory effects of four novel topical formulations combining synthetic anti-inflammatory drugs, antibiotics, and plant extracts in rat experimental models. Burn injury was induced in male Wistar rats for wound-healing assessment, while kaolin- and dextran-induced paw edema models were used to assess anti-inflammatory activity. The tested formulations were meloxicam, dexamethasone, and levofloxacin; thyme extract with meloxicam and dexamethasone; burdock extract with dexamethasone and levofloxacin; and thyme extract combined with burdock extract. Wound evolution was monitored macroscopically, edema was quantified by plethysmometry, and selected inflammatory mediators were measured by immunoassay. In the burn model, the thyme-containing formulation with meloxicam and dexamethasone, and the thyme–burdock formulation, achieved complete wound closure by the end of follow-up, whereas the reference product did not. In the acute inflammation models, all innovative formulations significantly reduced edema at the main early time points compared with the negative control and outperformed the reference product. The thyme–burdock formulation also showed the most favorable immunomodulatory profile, including normalization of interleukin-10 and marked reduction in interleukin-1 beta in both models. These results support the potential of multi-component topical formulations, particularly plant extract-based combinations, as promising candidates for veterinary wound care. Full article

Canine cognitive dysfunction (CCD) is a common age-related neurodegenerative disorder in dogs that shares several pathological and clinical features with human Alzheimer’s disease (AD). In both species, β-amyloid (Aβ) accumulates within the brain parenchyma and cerebral vessel walls and is associated with synaptic loss, oxidative stress, mitochondrial dysfunction, and chronic neuroinflammation, ultimately leading to progressive cognitive decline. Increasing evidence indicates that impairment of brain clearance mechanisms, particularly the glymphatic system, represents a central pathogenic mechanism in both CCD and AD. The glymphatic system is a glia-dependent perivascular network involved in the clearance of Aβ and other metabolic waste products from the brain. Its function declines with aging, vascular disease, and astrocytic alterations, including changes in aquaporin-4 distribution. Reduced glymphatic and periarterial drainage promotes the retention and aggregation of Aβ and tau proteins. Compared with AD, tau pathology in CCD is generally less extensive, supporting the interpretation of CCD as an Aβ-predominant condition and a partial pathological analog of Alzheimer’s disease. Clinically, CCD is characterized by a constellation of behavioral changes including, disorientation, altered social interactions, sleep–wake cycle disturbances, a loss of housetraining, changes in activity levels, and increased anxiety, commonly summarized by the DISHAA acronym. Overall, CCD represents a valuable spontaneous large-animal model for investigating neurodegenerative mechanisms and clearance-related therapeutic targets relevant to both veterinary and human medicine. Full article

Limited availability of veterinary medicinal products (VMPs) for small ruminants is a long-standing challenge. This mixed-methods study provides the first systematic definition and assessment of (i) shortages, (ii) lack of availability and (iii) unmet needs for sheep and goats across Europe. Survey data from 96 European veterinarians in 13 European countries (the majority of whom were from Spain, Germany, France, and Greece), a market analysis of authorized and available VMPs via the EMA Union Products Database (UPD) and expert knowledge elicitation (EKE) by 23 specialists were combined. Antimicrobials (36.7%) and nonsteroidal anti-inflammatory drugs (NSAIDs) (19.9%) were identified as the VMP categories most commonly perceived as critically important. Although nearly 5000 VMPs are authorized for small ruminants at the EU level, UPD market research reveals that there is a reported market availability of 28.9% of ovine and 32.7% of caprine authorized VMPs. Validation by EKE confirmed lack of VMP authorization to be the leading root cause of the lack of availability of ovine (31%) and caprine (43%) VMPs at both the national and EU level. The European Veterinary Medicines Gaps and Needs Compass identifies four highest-priority medicine groups lacking in availability for sheep (anthelmintics and endectocides, bacterial and viral vaccines) and two for goats (anthelmintics and bacterial vaccines). Moreover, 13 highest-priority unmet needs were identified for sheep and 14 for goats across antibacterials, analgetics and anti-inflammatories, antiparasitics and vaccines. Potential actionable solutions advised through EKE include harmonized market access pathways and targeted development (especially for vaccines, NSAIDs, and antibiotic teat injectors) to secure animal health, welfare, and One Health objectives. Full article

Antibiotics are used primarily in human and veterinary medicine to treat various infections. They have also found applications in animal farms and aquaculture as growth promotors, with the aim of increasing food production. Their uncontrolled use can lead to increased bacterial resistance to antibiotics as well as other adverse effects. Unfortunately, these can reach and accumulate in the environment. Thus, their sensitive and selective detection from various matrices, using inexpensive and portable instruments, is becoming an increasing necessity. Electrochemical techniques are a viable alternative in this regard, and carbon paste electrodes (CPEs) present electrochemical and economic characteristics that recommend them as versatile devices for this purpose. Therefore, this paper is a comprehensive synthesis of the information presented in the last 10 years in the literature regarding CPEs developed for the analysis of antibiotics in different samples. Methods for obtaining different modified CPEs and their performances in detecting compounds belonging to different classes of antibiotics were discussed and priorities for future development were suggested. Through this review, researchers interested in the (electro)analysis of antibiotics will gain information about the advantages and limitations of using CPEs and the efforts made in the last decade to improve their performance. Full article

The development of antimicrobial resistance (AMR) and the emergence of multiresistant pathogens represent a growing global threat to both human and animal health. Beyond the excessive and improper use of antimicrobials in human medicine, irrational use in veterinary medicine, agriculture, and aquaculture significantly contributes to the selection and spread of resistant microorganisms, which can enter the food chain and reach humans through food consumption or handling. Based on results from a recent meta-analysis, the prevalence of antimicrobial-resistant foodborne pathogens in food samples exceeds 10%. The veterinary sector is of particular concern, as a large proportion of antimicrobials are used in animal production, generating strong selective pressure and favoring the dissemination of AMR along the food chain. In an increasingly interconnected global context, resistant pathogens and resistance determinants can disseminate rapidly across sectors and national borders, making strategies confined to a single sector insufficient; therefore, effectively addressing AMR requires a One Health approach encompassing the human, veterinary, and environmental domains. Key mitigation strategies include strengthening antimicrobial stewardship programs, also in animal production, reducing routine prophylactic use of antimicrobials, and improving surveillance, coordinated across sectors and, where possible, further supported by advanced technologies such as artificial intelligence and machine learning. Further efforts are also needed to improve microbiological diagnostics, particularly through rapid and molecular methods, to support timely, targeted therapies and reduce inappropriate empirical treatments. In parallel, investment in new therapeutic options, including innovative molecules, drug combinations, and alternative approaches, remains crucial to effectively countering the growing burden of antimicrobial resistance. Full article

Infectious diseases continue to represent one of the most persistent challenges in human health and agricultural productivity. These diseases are caused by a wide range of pathogenic microorganisms, including bacteria, fungi, viruses, and parasites. Antimicrobial resistance, or AMR, is the gradual evolution of pathogenic microbes to evade the action of commonly used antimicrobial agents (antibiotics, antifungals, antivirals, and antiparasitics) and is a problem that continues to be exacerbated by the inappropriate use of antimicrobials across multiple global industries. AMR poses a major threat to our society, and without mitigation, will lead to devastating consequences with broad implications beyond human health. The search for alternative or complementary therapies to conventional antimicrobials is, therefore, of the utmost priority. In this review, we first outline the prevalence of AMR and the circumstances driving the proliferation of AMR, which is widely recognised as a One Health issue—through interconnected factors within human and veterinary medicine, agricultural practice, and the environment. We next summarise the various classes of pathogens, common antimicrobial agents, and the mechanisms which pathogens have evolved to evade antimicrobial action. Within this context, we discuss the therapeutic potential of bacteriophages, virophages, and mycoviruses against antimicrobial-resistant infections, and consider the future perspectives of virus-based formulations. Full article